Kaynaklar :

61. Saija A, Scalese M, Lanza M, et al. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 1995;19:481-486.

62. Miller AL. Antioxidant flavonoids: structure, function and clinical usage. Alt Med Rev 1996;1:103-111.

63. Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res1993;13:2165-2170.

64. Chen YT, Zheng RL, Jia ZJ, Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 1990;9:19-21.

65. DeWhalley CV, Rankin JF, Rankin SM, et al. Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol 1990;39:1743-1749.

66. Skaper SD, Fabris M, Ferrari V, et al. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med 1997;22:669-678.

67. Della Loggia ", Ragazzi E, Tubaro A, et al. Anti-inflammatory activity of benzopyrones that are inhibitors of cyclo- and lipo-oxygenase. Pharmacol Res Commun 1988;20:S91-S94.

68. Kim HP, Mani I, Ziboh VA. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase from guinea pigs. Prostaglandins Leukot Essent Fatty Acids 1998;58:17-24.

69. Fox CC, Wolf EJ, Kagey-Sobotka A, Lichtenstein LM. Comparison of human lung and intestinal mast cells. J Allergy Clin Immunol 1988;81:89-94.

70. Bronner C, Landry Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 1985;16:147-151.

71. Chaudry PS, Cabera J, Juliani HR, Varma SD. Inhibition of human lens aldose reductase by flavonoids,sulindac, and indomethacin. Biochem Pharmacol 1983;32:1995-1998.

72. Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol 1985;15:71-79.

73. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245-248.

74. Hertog MGL, Hollman PCH. potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr1996;50:63-71.

75. Scambia G, Raneletti FO, Panici PB, et al. Quercetin induces type-II estrogen-binding sites in estrogenreceptor- negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines. Int J Cancer 1993;54:462-466.

76. Scambia G, Raneletti FO, Panici PB, et al. Quercetin inhibits the growth of a multidrug-resistant estrogenreceptor- negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol 1991;28:255-258.

77. Singhal RL, Yeh YA, Prajda N, et al. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Comm 1995;208:425-431.

78. Larocca LM, Teofili L, Sica S, et al. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-B1 in these cells. Blood 1995;85:3654-3661.

79. Larocca LM, Teofili L, Leone G, et al. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. Br J Haematol 1991;79:562-566.

80. Pereira MA, Grubbs CJ, Barnes LH, et al. Effects of the phytochemicals, curcumin and quercetin, uponazoxymethane-induced colon cancer and 7,12-dimethylbenzy[a]anthracene-induced mammary cancer in rats.Carcinogenesis 1996;17:1305-1311.

81. Scambia G, Raneletti FO, Panici PB, et al. Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II). Gynecol Oncology 1992;45:13-19.

82. Scambia G, Raneletti FO, Panici PB, et al. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs 1990;1:45-48.

83. Castillo MH, Perkins E, Campbell JH. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 1989;158:351-355.

84. Yoshida M, Sakai T, Hosokawa N, et al. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Letters 1990;260:10-13.

85. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 2005 Mar 4;

86. Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 2000 Mar;25(6):639-45.

« Geri dönmek için tıklayınız.

Sayfa: 1 - 2 - 3